Skip to main content

New drug approved for duchenne muscular dystrophy

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, serving as the first of its kind.

Republish
Lead image for this article
Credit: Maria Kaloudi

The U.S. Food and Drug Administration approved a drug for all patients with child onset muscular dystrophy, the second drug approved for the disease and the first for everyone with the disorder. (Chicago Tribune)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Yes, I'll donate today

Information about the authors

Cassandra Pollock’s staff photo

Contributors

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics